Type I interferon-associated cytotoxic inflammation in lichen planus

Journal of Cutaneous Pathology

Volumn 33, Issue 10, 2006, Pages 672-678

  Wenzel, Joerg ^a   Scheler, Marina ^a   Proelss, Julia ^a   Bieber, Thomas ^a   Tüting, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; INTERFERON; MONOCLONAL ANTIBODY; MYXOVIRUS RESISTANCE PROTEIN A; STEROID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE SKIN DISEASE; CELL INFILTRATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTERFERON PRODUCTION; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MALE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SKIN BIOPSY; SKIN INFLAMMATION; TH1 CELL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; BIOPSY; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GRANZYMES; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON TYPE I; LICHEN PLANUS; MALE; MODELS, IMMUNOLOGICAL; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; RECEPTORS, CYTOKINE; TH1 CELLS;

EID: 33749569465     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00527.x     Document Type: Article

References (29)

1. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol 1991; 25: 593.
2. + T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol 2003; 163: 261.
3. Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 2000; 142: 449.
4. Kurkcuoglu N, Oz G. Lichen planus after genital herpes simplex virus type 2 infection. Dermatology 1995; 191: 72.
5. Rebora A. Lichen planus and the liver. Int J Dermatol 1992; 31: 392.
6. Pinto JM, Marques MS, Correia TE. Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. J Eur Acad Dermatol Venereol 2003; 17: 193.
7. Herrera Saval A, Camacho Martinez F. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma. Acta Derm Venereol 1999; 79: 395.
8. Bennion SD, Middleton MH, David-Bajar KM, Brice S, Norris DA. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995; 105: 71SS.
9. Fah J, Pavlovic J, Burg G. Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem 1995; 43: 47.
10. Wenzel J, Uerlich M, Wörenkämper E, et al. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin homing cytotoxic lymphocytes associated with strong expression of the type I interferon induced protein MxA. Br J Dermatol 2005; 153(5): 1011.
11. Wenzel J, Worenkamper E, Freutel S, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005; 205: 435.
12. Meller S, Winterberg F, Gilliet M, et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52: 1504.
13. Wenzel J, Uerlich M, Gaffal E, Bieber T, Tuting T. Type I interferon induced Th1 biased cytotoxic inflammation: a common mechanism in regressive melanocytic lesions. Am J Clin Pathol 2005; 124: 1.
14. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69.
15. Haller O, Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002; 3: 710.
16. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237.
17. Santoro A, Majorana A, Roversi L, et al. Recruitment of dendritic cells in oral lichen planus. J Pathol 2005; 205: 426.
18. + effector T cells. J Leukoc Biol 2002; 71: 669.
19. Suomela S, Cao L, Bowcock A, Saarialho-Kere U. Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J Invest Dermatol 2004; 122: 717.
20. Sharif MN, Tassiulas I, Hu Y, Mecklenbrauker I, Tarakhovsky A, Ivashkiv LB. IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol 2004; 172: 6476.
21. Kohrgruber N, Groger M, Meraner P, et al. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 2004; 173: 6592.
22. Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. J Immunol 1989; 143: 4282.
23. Guillot B, Portales P, Du Thanh A, et al. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment. Br J Dermatol 2005; 152: 690.
24. Funk J, Langeland T, Schrumpf E, Hanssen LE. Psoriasis induced by interferon-alpha. Br J Dermatol 1991; 125: 463.
25. Ladoyanni E, Nambi R. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia. J Drugs Dermatol 2005; 4: 221.
26. + lymphocytes in cutaneous cytotoxic T cell lymphoma and pityriasis lichenoides. J Am Acad Dermatol 2005; 53: 422.
27. Wenzel J, Scheler M, Tuting T, Bieber T. Evidence for a role of type I interferons in dermatomyositis. Br J Dermatol 2005; 153: 462.
28. Dietrich LL, Bridges AJ, Albertini MR. Dermatomyositis after interferon alpha treatment. Med Oncol 2000; 17: 64.
29. Wenzel J, Uerlich M, Haller O, Bieber T, Tueting T. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. J Cutan Pathol 2005; 32: 257.